NEFL and Alzheimer disease: The findings reinforce the applicability of NfL as a non-invasive, easily accessible biomarker that can potentially improve the precision of AD diagnoses, refine the assessment of disease progression, and aid in the tailoring of therapeutic interventions at stages where they may have the most substantial impact.